 |
|
Sydney scientists discover and license breakthrough anti-inflammatory treatment
February 08, 2006Scientists from the Garvan Institute of Medical Research have developed what could be the next big blockbuster treatment for inflammatory diseases such as rheumatoid arthritis and asthma.
This discovery is being commercialised by G2 Therapies Ltd, a biotechnology company founded by Garvan, which today announced the signing of an AU$135 million research, development and licensing agreement with Danish healthcare company, Novo Nordisk. The terms of the agreement include an upfront payment and other success-based payments to a potential total of around US$100 million (A$135 million), plus royalties on commercialised therapeutics. The partnership will enable the new therapy to be taken through to human clinical trials.
Professor Charles Mackay, Head of Garvan's Arthritis & Inflammation Program and founder of G2 Therapies, says: "We have done what many others have been trying to do for years. We have made a therapeutic antibody against one of the most potent inflammatory agents in the body and used it to cure arthritis in mice. The next step is to translate the highly effective outcome we see in mice to human patients. If we can do this, we will have a revolutionary new treatment for a number of important human diseases".
The body needs a certain amount of inflammation to protect itself against disease. The hallmarks of inflammation reflect the major events: swelling of localised blood capillaries, and the movement of fluid and immune cells into damaged tissue in an effort to contain infection.
When immune cells become overactive, as is the case with rheumatoid arthritis, too many of them move into damaged tissue and exacerbate the condition. The new antibody blocks the action of one of the most important molecules for guiding inflammatory cells into tissue.
"We anticipate that our antibody will be a significant improvement over current therapies because it acts at a different and earlier point in the inflammatory process compared with current anti-inflammatory therapies," says Mackay.
Rheumatoid arthritis (RA) alone affects more than 21 million people worldwide and causes swelling of major joints, severe pain, and fatigue. In addition to treating RA, Professor Mackay believes their therapeutic could also be used for psoriasis, sepsis, heart attack and transplant patients.
Professor John Shine FAA AO, Executive Director of the Garvan Institute says: "It is important to work with companies if we are to turn scientific discoveries into real patient benefits. The Garvan's commitment to taking our research from bench to bedside is evidenced by our investment in companies such as G2 and encouraging our senior scientists to participate in the commercialisation of research".
The Novo Nordisk licensing agreement has a potential value of over US$100 million (A$135 million), making it one of the largest licensing agreements ever secured by an Australian biotechnology company. Going forward, the Garvan Institute and G2 will remain involved in the crucial stages of development, making the deal one of the few true partnerships between academia and industry.
Commenting on the deal, Mr Bill Ferris AO, Chairman of the Garvan Institute's Board, says: "This is an exciting example of what is possible when you back early stage research with venture capital and encourage discoveries to develop in-house. Facilitating venture capital investment in medical research will ensure that all Australians will benefit from home-grown medical advances like the new anti-inflammatory treatment that has been developed at the Garvan."
Research Australia
The body needs a certain amount of inflammation to protect itself against disease. The hallmarks of inflammation reflect the major events: swelling of localised blood capillaries, and the movement of fluid and immune cells into damaged tissue in an effort to contain infection.
When immune cells become overactive, as is the case with rheumatoid arthritis, too many of them move into damaged tissue and exacerbate the condition. The new antibody blocks the action of one of the most important molecules for guiding inflammatory cells into tissue.
"We anticipate that our antibody will be a significant improvement over current therapies because it acts at a different and earlier point in the inflammatory process compared with current anti-inflammatory therapies," says Mackay.
Rheumatoid arthritis (RA) alone affects more than 21 million people worldwide and causes swelling of major joints, severe pain, and fatigue. In addition to treating RA, Professor Mackay believes their therapeutic could also be used for psoriasis, sepsis, heart attack and transplant patients.
Professor John Shine FAA AO, Executive Director of the Garvan Institute says: "It is important to work with companies if we are to turn scientific discoveries into real patient benefits. The Garvan's commitment to taking our research from bench to bedside is evidenced by our investment in companies such as G2 and encouraging our senior scientists to participate in the commercialisation of research".
The Novo Nordisk licensing agreement has a potential value of over US$100 million (A$135 million), making it one of the largest licensing agreements ever secured by an Australian biotechnology company. Going forward, the Garvan Institute and G2 will remain involved in the crucial stages of development, making the deal one of the few true partnerships between academia and industry.
Commenting on the deal, Mr Bill Ferris AO, Chairman of the Garvan Institute's Board, says: "This is an exciting example of what is possible when you back early stage research with venture capital and encourage discoveries to develop in-house. Facilitating venture capital investment in medical research will ensure that all Australians will benefit from home-grown medical advances like the new anti-inflammatory treatment that has been developed at the Garvan."
Research Australia
Anti-inflammatory Treatment Current Events and Anti-inflammatory Treatment News RSSPain thresholds linked to inflammation and sleep problems in arthritis patients
Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis (RA) patients continue to suffer from pain.
Myeloid proteins reflect disease activity and treatment response in familial Mediterranean fever
Serum levels of the pro-inflammatory biomarkers myeloid-related protein (MRP) 8 and 14 are increased to a greater extent in patients with Familial Mediterranean Fever (FMF) during flare than in patients with Neonatal-Onset Multisystem Inflammatory Disease (NOMID) or patients with Muckle Wells Syndrome (MWS).
Asthma drugs need to be maintained for continued benefit
Children whose asthma improved while taking steroid drugs for several years did not see those improvements continue after stopping the drugs, new results from a comprehensive childhood asthma study show.
NO help: Nitric oxide monitoring does not help most children with asthma
The level of nitric oxide (NO) in an asthmatic's exhaled breath can portend worsening asthma symptoms, and may even signify an imminent attack linked to underlying airway inflammation.
Ibuprofen associated with slower lung function decline in children with cystic fibrosis
Treatment with ibuprofen is associated with a significantly slower rate of decline in lung function in children and adolescents with cystic fibrosis, according to a new study.
Coarse particulate matter in air may harm hearts of asthma sufferers, UNC study finds
Breathing air containing coarse particulate matter such as road or construction dust may cause heart problems for asthma sufferers and other vulnerable populations, according to a new study led by the University of North Carolina at Chapel Hill School of Public Health.
Minimally invasive treatment helps infertile couples conceive
Couples struggling with infertility face uncertain odds when considering various treatment options. But a new study reveals that embolization, a minimally invasive treatment for arguably the most common cause of infertility in men, can significantly improve a couple's chances for pregnancy.
Omega-3 fatty acids may slow cognitive decline in some patients with very mild Alzheimer's disease
Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer's disease, but do not appear to affect those with more advanced cases.
Quitting smoking improves lung function considerably
For smokers with asthma, quitting smoking can improve lung function test scores by more than 15 percent in less than two months.
More Anti-inflammatory Treatment Current Events and Anti-inflammatory Treatment News Articles
 |
Fish Oil: The Natural Anti-inflammatory by Joseph C. Maroon (Author), Jeffrey Bost (Author) Did you know that the root cause of serious chronic diseases such as heart disease, Alzheimer's disease, cancer, arthritis, and asthma has been identified as chronic inflammation? Although numerous studies have confirmed these findings, few physcians are aware of or consider the fact that the battle against inflammation is at the forefront of the fight for health and well-being of the global population. Authors Joseph Maroon and Jeffrey Bost have set out to reverse that trend with "Fish Oil: The Natural Anti-Inflammatory." Pharmaceujtical companies have spent billions of dollars in an attempt to understand the bio-chemistry of inflammation. Unfortunately, pharmaceutical anit-inflammatories such as Celebrex, Vioxx, and Bextra have been shown to greatly increase the risk of heart attack,... |
 |
Anti-Inflammatory Facial Treatment-2 oz. by Body Time This dramatically effective serum aggressively alters the skins behavior reducing acne and giving the skin a healthier appearance following just two months of regular use. Young people just beginning puberty and getting pimples and women experiencing hormonal breakouts find this treatment especially effective. Active ingredients of capryloyl glycine, sarcosine and cinnamon bark extract reduce acne by counteracting the main causes of skin imbalance including regulating sebum rate, inhibiting bacteria growth, reducing free fatty acids that block skin follicles, reducing inflammation and fighting free radicals. Contains scar preventing gotu kola extract and alpha hydroxy acids that gently exfoliate while aloe vera gel and essential oils of melaleuca, tea tree, lavender and combava help... |
 |
Native Remedies Gastronic Doctor Capsules, 60-Count Bottle by Native Remedies Gastronic Dr. is a 100% natural, safe and proven herbal tonic with fast, effective relief of digestive upset. DigestAssist may be taken after meals to maintain digestive comfort and to promote healthy digestion. Gastronic Dr. facilitates the digestive system's natural ability to digest food without heartburn, acid or gas. Gastronic Dr. is a capsule which is used every day for the digestive tract and as a preventative for flare ups of stomach and digestive disorders such as IBS, Crohn's Disease, Gastritis, Acid Reflux (GERD), Ulcerative Colitis and Diverticulosis. Gastronic Dr. safely and effectively acts to improve digestive health, reduce inflammation and reduce and prevent digestive disorders. |
 |
ARCONA Eye Dew, Repair/Protect AM .3 oz (9 ml) by Arcona, Inc. Protective anti-aging formula hydrates and revitalizes eye area. Prevent deepening of fine lines and wrinkles with shea butter, hyaluronic acid and essential fatty acids acting as a barrier to the elements. Repair damaged skin and increase elasticity around the eyes with beta-fructan and liquid crystals. Heal and soothe skin with anti-inflammatory blueberry extract and vitamin E. Idea for under-makeup application. Like all products in ARCONA's skin therapy regimen, Eye Dew is cosmeceutically formulated with pure, natural ingredients, cold-processed in small batches to keep them fresh, active and super-effective. For optimal results, we recommend using this product within six months of opening. Change may be immediately noticeable; however, full benefits are derived as skin is brought... |
|
Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Chronic Glomerulonephritis: A Clinical and Experimental Study by Y. Vanrenterghem (Author) | |
 |
Dr. Perricone's Guide to Cosmetics and Topical Treatments DVD Nicholas Perricone MD brings his years of expertise in the area of topical treatments and cosmeceuticals to this one-on-one interactive DVD. Learn the secrets to fighting pro-inflammatory skin conditions including acne, psoriasis, wrinkles, uneven skin tone, and many of the signs of aging. |
 |
The Arthritis Handbook: Improve Your Health and Manage the Pain of Osteoarthritis (A DiaMedica Guide to Optimum Wellness) by M.D. Grant Cooper (Author) According to conventional wisdom, arthritis pain is an inevitable part of aging. Not so, says Dr. Grant Cooper in this practical, accessible guide. For those who do develop osteoarthritic conditions, this book offers a blend of commonsense advice, dietary info, targeted exercise, and tips on useful supplements. According to the author, sufferers can often entirely avoid the use of medication, injection therapy, and surgery — approaches that, when necessary, can be used as an opportunity to return to exercise and nutrition to slow the disease’s progress. The book features easy, illustrated exercises, including aerobics and strength training, that can be done at home, at a gym, or under a trainer’s or physical therapist’s supervision. Nutritional and supplement strategies —... |
 |
ASTHMA TREATMENT FOR ADULT whit Astexpect Natural Anti-inflammatory and expectorant. Adult asthma, natural healing integral in 3 months and 8 treatments at 1, 4 products, does not affect the heart. by AAA Abril Natura sac Expectorant and natural anti-inflammatory of Asteraceas. It relieves the asthma; cleans the bronchi, reduces the sore throat (candy kof-kof) and the pain of the lungs. In addition,uña de gato to get defenses and banana flour to improve the lung tissue. Accompanied by diet for asthmatics, steam baths, physical exercises and sahumerios (8 treatments in one). |
 |
Natural Alternatives To Vioxx, Celebrex & Other Anti-inflammatory Prescription Drugs by Carol Simontacchi (Author) |
 |
Famous Wuyi Rock Oolong (Wu Long) Tea - Da Hong Pao Loose Leaf Tea - 2x4.5 Oz by Harmony Tea Garden The original bushes, growing on a rock on Mount Wuyi, still survive today and are highly venerated, which fetched a record high bid of over $1 million USD for 2.2 lbs in 1998. The Da Hong Pao on the market now are the plant grow from the cut of the original plants to product similar grades of tea from original plants. Taste variations produced by processing, differences in the soil, and location of these later generation plants. |
| © 2009 BrightSurf.com |